Originally presented September 26, 2018 as part of the UNC Cancer Network Medical and Surgical Oncology Lecture Series. This Self-Paced, Online Course expired December 4, 2019.
This is a Non-Credit course and does NOT offer continuing education credits.
Presenter
Simon Khagi, MD
Assistant Professor, Medicine and Neurosurgery
Director, UNC Brain Tumor Program
Department of Neurosurgery
UNC Lineberger Comprehensive Cancer Center
UNC School of Medicine
University of North Carolina at Chapel Hill
Aerobic and Resistance Exercise in Cancer Patients: Methods and Benefits
Glioblastoma is a devastating disease with a survival that is measured in months. The recent FDA approval of the Optune device for the treatment of newly-diagnosed glioblastoma was a paradigm shift in the field of neuro-oncology. We will focus our discussion on the biological underpinnings of this device and clinical data supporting its use.
Learning Outcomes
- Discuss the outcomes and treatment of glioblastoma before the introduction of Optune
- Explain the mechanism of actions and early research that led to the approval of Optune by the FDA
- Describe the evolving role of Optune in the management of glioblastoma
Credits Offered
- 1.0 ANCC (CNE) hours of study.
- 1 ASRT Category A CE Credit
- 1.0 AMA PRA Category 1 Credit™
- General Participation
Requirements
To receive credit for this course, you must:
- Watch a lecture video recording.
- Complete the lecture post test and obtain a passing score of 80% or higher.
- Complete the course evaluation.
- Select credit type.
Estimated course completion time: 1 hour
Disclosures
This activity has been planned and implemented under the sole supervision of the course directors, in association with the UNC Office of Continuing Professional Development (UNC CPD). Dr. Thomas Shea consults for Spectrum Pharma and receives research support from Millennium, Otsuka, GSK, BMS, Novartis and Seattle Genetics. Dr. James Coghill, MD, and CPD staff have no relevant financial relationships with commercial interests as defined by the ACCME.
The speaker, Simon Khagi, MD, has no relevant financial relationships with commercial interests as defined by the ACCME.
Accreditation
This is a Non-Credit course and does NOT offer continuing education credits.
Disclaimer
Please note: This course was published more than one year ago. The facts and conclusions presented may have since changed and may no longer be accurate. Questions about personal health should always be referred to a physician or other health care professional.